Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 49th Annual Midwinter Meeting
MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes... Read more.
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti,... Read more.
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$RARE—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit... Read more.
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$MREO—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit... Read more.
GoodRx Powers Pricing for Leading Brand Medications on TrumpRx
Brief Summary: GoodRx is a core integration partner for TrumpRx, powering the pricing for leading brand medications At launch, GoodRx is the integrated pricing source... Read more.
Applied Medical Prevails in Antitrust Jury Trial Against Medtronic
Jury Awards $382 Million in Damages RANCHO SANTA MARGARITA, Calif.–(BUSINESS WIRE)–Applied Medical announced today a significant legal victory that should... Read more.
Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans
Program offers significant savings on over 30 brands spanning women’s health, migraine, arthritis, rare disease and more Affirms Pfizer’s commitment to reduce... Read more.
Once Upon a Farm Announces Pricing of Initial Public Offering
BERKELEY, Calif.–(BUSINESS WIRE)–Once Upon a Farm today announced the pricing of its initial public offering of 10,997,209 shares of its common stock,... Read more.
Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
Procedural success was achieved in 100% of evaluable patients at 6 months and 96% in 12 months HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc.... Read more.
Law Offices of Howard G. Smith Encourages Oracle Corporation (ORCL) Shareholders To Inquire About Securities Fraud Class Action
BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased... Read more.